Hanshang Group Co., Ltd. (SHSE: 600774)
Health Care · Pharmaceuticals · CN
CN¥7.32
+0.83% today · -29.1% 1Y
Hanshang Group Co., Ltd. (SHSE: 600774) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $314.70M and employs 2,123 people.
Over the last twelve months the share price has lost 29.1%, trading between 5.84 and 11.64.
Tweenvest scores Hanshang Group Co., Ltd. across four factors: quality 51/100, value 37/100, growth 0/100. Its strongest factor is quality.
600774 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $314.70M
- Revenue (TTM)
- $145.29M
- P/E
- —
- EPS
- -0.62
- Dividend yield
- —
- Beta (5Y)
- 0.72
- 52-week high
- CN¥11.64
- 52-week low
- CN¥5.84
- Avg volume (3M)
- —
- Shares outstanding
- 289.01M
- Employees
- 2,123
- Next earnings
- —
About Hanshang Group Co., Ltd.
Hanshang Group Co., Ltd. primarily engages in the retail business. It is also involved in medicine, medical equipment, assisted reproduction, healthy drinks, and exhibition operations. The company was incorporated in 1990 and is based in Wuhan, China.
- ISIN
- CNE000000NC5
- Founded
- 1990
- Listed since
- Nov 8, 1996
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.